Congratulations on 97% profit from the recommended free trial stock for June, SolgoBio (043100)!
Global official certification acquired at once! Exclusive beneficiary highly likely! [Follow-up stocks free disclosure]
The moment the material is revealed, investors will rush like crazy to this golden stock! This is your last chance.
Immune boosters essential for mass production of mRNA vaccines! A market monopolized by a few companies worldwide
FDA emergency approval issue for XXX virus treatment!
Last chance to recover principal!! World’s first XXX treatment [This stock will explode]
Tomorrow is too late! Institutional accumulation already completed! Undervalued bottom stock, price will soon explode.
High-rising stocks are always in bio!! Quietly explode at once bringing hundreds of percent profit.
“I followed others and IPOs but only suffered huge losses. When I thought it wouldn’t work, I received information from experts and painfully learned that I had invested wrongly all along. Since the 3-day free trial, I have only been making profits. I am receiving VIP service and only profits are left to increase.” (VIP member Kang Su-yeon, 34 years old)
[Limit-up hits]
*21.05.31 Sambo Industry (009620) limit-up hit!
*21.05.25 Ilyeon Pharmaceutical (102460) limit-up hit!
*21.05.20 Daeduk (008060) limit-up hit!
*21.05.14 Igen (185490) 2nd limit-up hit!
*21.04.25 Next Science (003580) 2nd limit-up hit!
*21.04.13 IOK (078860) 2nd limit-up hit!
*21.04.05 Humasis (205470) limit-up hit!
*21.03.26 Phoenix Materials (050090) limit-up hit!
*21.03.23 Hyein (003010) limit-up hit!
*21.03.11 Korea Electronics Holdings (006200) 2nd limit-up hit!
*21.03.02 Duol (016740) limit-up hit!
*21.02.25 Hyundai Bio (048410) limit-up hit!
*First-come, first-served 20 people closed! Both early and late rounds are over. The hero of the last injury time winning goal*
[Today’s stocks of interest]
#SolgoBio #Plantinet #ECS #Igen #NatureAndEnvironment
※ This content is unrelated to Asia Economy’s editorial direction, and all responsibility lies with the information provider.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

